Following the success of our inaugural 2025 conference, this two-day event will once again bring together researchers, clinicians, people affected by epilepsy, funders and partners from across the epilepsy community.
Held every two years, our conference exists to strengthen the epilepsy research ecosystem by driving collaboration, sharing knowledge and raising the profile of epilepsy. By bringing together diverse perspectives and expertise, we can accelerate scientific discovery and radically advance research into epilepsy, helping to drive meaningful progress towards a future free from epilepsy.
We are delighted to welcome Helen Bateup, Associate Professor of Neurobiology at the University of California, Berkeley as one of our keynote speakers, who will share her expertise and insights on animal and human models of epilepsy.
“I am honoured to join the Epilepsy Research Institute Conference as a keynote speaker and share our team’s work using mouse and human brain organoid models to study Tuberous Sclerosis Complex. By leveraging these complementary approaches, we hope to unravel the mechanisms underlying pediatric and focal epilepsies to help identify novel therapeutic targets. I look forward to engaging with the UK research community and discussing how pre-clinical science can inform future treatment strategies.”
Dr Helen Bateup
Explore the programme and discover what’s in store at our 2027 Conference here.
Present your researchSubmit a 300-word abstract for an oral or poster presentation. Deadline: 2 December 2026 Download the abstract form and email to [email protected]. |
The Epilepsy Research Institute’s mission is to radically advance research for the one in 100 people living with the condition. We serve as the central hub for the epilepsy research community.
Guided by the epilepsy community’s priorities, our research model is built on the below six key themes:
Each theme is led by expert working groups of scientists, clinicians and emerging talent. Crucially, we involve people affected by epilepsy in every stage of the research process as we work to advance understanding, prevention and treatment.
By driving awareness, strategic funding and collaboration across academia, government, the NHS, industry and patient groups, we are turning bold ideas into real world impact.
